Targeting mTOR for the treatment of AML. New agents and new directions

Despite recent advances in the field, the treatment of patients with acute myeloid leukemia (AML) remains challenging and difficult. Although chemotherapeutic agents induce remissions in a large number of patients, many of them eventually relapse and die. A major goal for the development of new appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Altman, Jessica K., Sassano, Antonella, Platanias, Leonidas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2011
Materias:
Research Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248202/
https://www.ncbi.nlm.nih.gov/pubmed/21680954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248202/
https://www.ncbi.nlm.nih.gov/pubmed/21680954

Ejemplares similares